Acquired hemophilia as first manifestation of breast carcinoma in a man under long-term spironolactone therapy.
Fiche du document
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10147-003-0372-2
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/15108046
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1341-9625
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A30146D0EE457
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Haemophilia Hematophilia Classic hemophilia Factor VIII deficiency Hemophilia A Hemorrhagic diathesis Carcinoma Cancers Malignancy (Cancer) Malignant tumors BreastsCiter ce document
O. Lamy et al., « Acquired hemophilia as first manifestation of breast carcinoma in a man under long-term spironolactone therapy. », Serveur académique Lausannois, ID : 10.1007/s10147-003-0372-2
Métriques
Partage / Export
Résumé
A 69-year-old man under long-term spironolactone therapy (16 years) was hospitalized with spontaneous hematoma on the trunk and extremities. Coagulation studies disclosed an acquired hemophilia that was successfully treated with human factor VIII for a few days and immunosuppressive agents for several months. Physical examination revealed bilateral gynecomastia and an upper left quadrant breast nodule. Complete staging was unremarkable. Complete left mastectomy was performed. Histopathology showed invasive ductal carcinoma, expressing positivity for estrogen and progesterone receptors. The acquired hemophilia was considered to be a paraneoplasic syndrome. The question of a linkage between long-term spironolactone therapy and breast carcinoma is discussed.